dr reddy's glp-1 drugs portfolio 2025 Lilly's GLP-1 portfolio gains ground on Novo Nordisk Ozempic and other GLP-1 drugs
Description
Resistin is a key mediator of glucosedependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes
[DOI] [PMC free article] [PubMed] [Google Scholar] 112
SS: Investigation, Methodology, Writing original draft, Software, Formal analysis, Data curation, Resources
The density of activity reflects the commercial prize of an effective oral alternative to injection
